
Regeneron Pharmaceuticals REGN
$ 649.76
3.09%
Quarterly report 2026-Q1
added 04-29-2026
Regeneron Pharmaceuticals Depreciation & Amortization 2011-2026 | REGN
Annual Depreciation & Amortization Regeneron Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 544 M | 483 M | 421 M | 341 M | 286 M | 236 M | 210 M | 148 M | 146 M | 105 M | 74.9 M | 52.7 M | 41.2 M | 36.9 M | 31.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 544 M | 31.1 M | 210 M |
Quarterly Depreciation & Amortization Regeneron Pharmaceuticals
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 M | - | 127 M | - | - | 114 M | - | - | 99.5 M | - | 241 M | - | 74.3 M | - | 212 M | - | 67.4 M | - | 174 M | 115 M | 56.1 M | - | 156 M | 103 M | 51 M | - | 105 M | 70 M | 36.4 M | - | 111 M | 73.2 M | 38.1 M | - | 75.8 M | 48 M | 23 M | - | 52 M | 31.3 M | 16 M | - | 38.6 M | 24.5 M | 11.5 M | - | 29.9 M | 19.1 M | 9.41 M | - | 27.2 M | 17.8 M | 8.42 M | - | 23.2 M | 14.9 M | 6.98 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 241 M | 6.98 M | 69.1 M |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
380 K | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
AstraZeneca PLC
AZN
|
5.73 B | - | - | $ 96.9 B | ||
|
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | ||
|
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | ||
|
Esperion Therapeutics
ESPR
|
105 K | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
4.04 M | $ 34.45 | 4.74 % | $ 927 M | ||
|
Forte Biosciences
FBRX
|
64 K | $ 20.31 | 1.2 % | $ 263 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
3.02 M | $ 6.82 | 1.94 % | $ 187 M | ||
|
Generation Bio Co.
GBIO
|
4.93 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.62 | -0.61 % | $ 431 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
5 K | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
475 K | $ 2.71 | -0.92 % | $ 253 M | ||
|
Anika Therapeutics
ANIK
|
5.37 M | $ 15.14 | 2.16 % | $ 217 M | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
93.3 M | $ 97.08 | 1.55 % | $ 19 B | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.39 | 4.17 % | $ 5.58 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
1.3 M | $ 1.51 | 2.03 % | $ 177 M | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
7.72 M | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 20.47 | 4.97 % | $ 2.6 B | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K |